Xamic MF Tablet is a combination medication containing Tranexamic Acid 500 mg and Mefenamic Acid 250 mg, formulated to manage conditions involving excessive bleeding and pain. Tranexamic Acid is an antifibrinolytic agent that inhibits the breakdown of fibrin clots by competitively blocking lysine binding sites on plasminogen molecules, thereby promoting hemostasis. This action makes it effective in reducing heavy menstrual bleeding (menorrhagia) and controlling hemorrhage in various clinical settings. Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), provides analgesic, anti-inflammatory, and antipyretic effects by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins responsible for pain and inflammation. The combination of these two agents in Xamic MF Tablet offers dual benefits: controlling excessive bleeding while alleviating associated pain and inflammation, particularly in gynecological disorders such as dysmenorrhea and menorrhagia. It is indicated for short-term use under medical supervision, with caution advised in patients with renal impairment, peptic ulcer disease, or hypersensitivity to NSAIDs or tranexamic acid. Adverse effects may include gastrointestinal discomfort, nausea, and rare hypersensitivity reactions. Xamic MF Tablet should be used as prescribed by a healthcare professional to ensure safety and efficacy.